This is the "Home" page of the "Grand Rounds 06/17/15 @ BID-Needham: Dr. Joseph Li" guide.
Alternate Page for Screenreader Users
Skip to Page Navigation
Skip to Page Content

Grand Rounds 06/17/15 @ BID-Needham: Dr. Joseph Li  

New Drugs of 2014 and Their Therapeutic Use
Last Updated: Jun 23, 2015 URL: http://bidmc.libguides.com/Li/2015 Print Guide RSS Updates
Home Print Page
  Search: 
 

Speaker: Date: Topic

Joseph Li, MD

Jun 17, 2015

New Drugs of 2014 and Their Therapeutic Use

      

    Responsibility for Content

    The PowerPoint presentation, Take-Away points, and Article links were sent by Medical Library Services and the CME Committee.

    Diane E. Young, Information Specialist

    dyoung3@bidmc.harvard.edu

     

        
       

      Feedback Welcome

      Was this information helpful?

      How useful is this page?
      (1 = Not Useful, 5 = Very Useful!)

      Additional comments:


      Your Email:


      Take-Away Points of the Presentation

      1. Ketoacidosis is a newly discovered side effect of the SGLT2 inhibitors.

      2. Oritavancin can interfere with the results of PTT, PT/INR results.

      3. Sofosbuvir co-administration with amiodarone is not recommended due to potential development of symptomatic bradycardia.

          
         

        Links to Articles Cited in the Presentation

         

        PDF of the PowerPoint Presentation

        WebEx Video of the Presentation

        Not available at this time.

            

          Pre- and Post-Test Questions

          Not available at this time.

              

            THIS SITE IS MAINTAINED BY KNOWLEDGE SERVICES AT THE BETH ISRAEL DEACONESS MEDICAL CENTER.
            CLICK HERE TO ASK A QUESTION OR REPORT A PROBLEM.

            Description

            Loading  Loading...

            Tip